Overview
Status
Active
Registry date
2011-04-18
Share capital
10,000,000.00 PLN
Registered address
Wrocław, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Artur Stechmiller – President of the Management Board
Manner of representation
The following are authorised to submit declarations on behalf of the company: the President of the Management Board independently, or two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy.
Supervisory board
Paweł Drzewiecki – Supervisory Board Member
Marcin Dudzik – Supervisory Board Member
Felicja Wójciak – Supervisory Board Member
Grzegorz Wójciak – Supervisory Board Member
Mieczysław Wójciak – Supervisory Board Member
Beneficial owners
No beneficial owners recorded for the company Jantar Development.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 5, 2023 | Dissolution without liquidation opened | |
| Nov 19, 2012 | Commercial Companies Code notice |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| Olenasp. z o.o. | – | imsolutions.pl | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com |
Change history
| Date | Event | |
|---|---|---|
| 2018-11-14 | Address change (Pl. Solny 14/3, 50-062, Wrocław → Wrocław) | |
| 2015-08-18 | Name change (Msi Bioscience → Jantar Development) | |
| 2015-07-31 | Address change (Pl. Powstańców Śląskich 1/201, 53-329, Wrocław → Pl. Solny 14/3, 50-062, Wrocław) | |
| 2015-02-24 | Share capital increase (1,768,182.00 PLN → 10,000,000.00 PLN) | |
| 2015-02-20 | Address change (Świętojańska 114, 81-388, Gdynia → Pl. Powstańców Śląskich 1/201, 53-329, Wrocław) |
FAQ
The main business activity of Jantar Development focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on April 18, 2011.
The headquarters is located at: Wrocław.
The share capital of the company is PLN 10,000,000 (approx. $2.7 million).
Last updated: 2026-03-23